Tech Company Financing Transactions
Monarch Biosciences Funding Round
Monarch Biosciences closed a $1 million Seed funding round on 4/9/2020. Investors included Checkmate Capital and private investors.
Transaction Overview
Company Name
Announced On
4/9/2020
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Seed
Investors
Checkmate Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds for the development of its biomaterial-based neurovascular stent and platform for local delivery of cell therapies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10960 Wilshire Blvd. 1910
Los Angeles, CA 90024
USA
Los Angeles, CA 90024
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
MonarchBio is commercializing next generation medical device & biotechnology products based on Thin Film Nitinol technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leon Ekchian
Browse more venture capital transactions:
Prev: 4/9/2020: Sila venture capital transaction
Next: 4/9/2020: Arturo venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs